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Summary: The effects of caffeinated and non-caffeinated paracetamol administration, with or without 
vitamins A and E supplementation on the protein and enzyme levels in Wistar albino rats were 
investigated using cafeinated paracetamol and paracetamol as caffeinated and non-caffeinated 
paracetamol respectively, and water soluble acetic acid derivatives of vitamins A and E.  Serum AST, 
ALT and ALP levels (u/l) significantly increased (P<0.05) following paracetamol administration.  
Caffeination as well as administration of vitamins A and E caused significant decreases (P<0.05) in 
AST and ALP levels in all test groups when co-administered with paracetamol and in ALT level except 
in the cafeinated paracetamol + Vitamin E group in which ALT and ALP level except in the cafeinated 
paracetamol + vitamin E group in which ALT and ALP levels significantly increased (P<0.05).  Total 
serum protein level (g/100ml) significantly increased following caffeination as well as during co-
administration of cafeinated paracetamol and Vitamin E; and significantly decreased during co-
administration of paracetamol and vitamin A.  Paracetamol administration without caffeination or 
supplementation with vitamin A and E can therefore cause increases in serum liver enzymes that is 
suggestive of liver necrosis which can be ameliorated to varying degrees by caffeine, vitamin A and E.
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Introduction
Paracetamol or acetaminophen is a 
popular domestic analgesic and antipyretic for 
adults and children. It is a major metabolite of 
the now obsolete phenacetin, with an analgesic 
effect, which is similar to that of aspirin. In 
therapeutic doses, acetaminophen is usually 
well tolerated and free from side effects and 
interactions with other drugs. Its easy 
availability as well as ease of acquisition to the 
public even without prescription has led to the 
increase in reported cases of toxicity caused by 
paracetamol. The first reports of paracetamol 
poisoning in humans describing hepatic necrosis 
provoked a series of animal studies which 
demonstrated that acute centrilobular hepatic 
necrosis with collapse of the reticulum 
framework could be produced in some species, 
although there were differences in susceptibility 
in various species (Thomas, 1993).
In adult humans, hepatotoxicity may 
occur after ingestion of a single dose of 10 to 
15g (150 to 250 mg/kg) of acetaminophen; 
doses of 20 to 25g or more are potentially fatal. 
Clinical indications of hepatic damage become 
manifest within 2 to 4 days of ingestion of toxic 
doses. Plasma aminotransferases are elevated 
and the concentration of bilirubin in plasma 
may be increased and prothrombin time is 
prolonged. About 10% of poisoned patients who 
do not receive specific treatment develop severe 
liver damage; of these, 10 to 20 % eventually 
die of hepatic failure. Biopsy of the liver reveals 
centrilobular necrosis with sparing of the 
periportal area (Hardman et at, 1996).    
Co-administration of paracetamol using 
fixed ratio drug combinations is increasingly 
gaining popularity. 500mg paracetamol with 
30mg caffeine preparations are increasingly 
being introduced into the market in various 
trade names like cafeinated paracetamol, 
Medik-55, Boska etc. Tablets containing 
paracetamol (325mg) plus 32.5mg of 
dextropropoxyphene (co-proxamol, Distalgesic) 
have been used to provide an effective dose of 
both drugs as well as give a mild euphoriant 
effect. Despite the benefit of rapid analgesic 
effect and the probable decrease in toxicity, co-
administration with these agents is still a cause 
of concern (Laurence et al, 1997).
Experimental evidence suggests that 
stress may contribute to degenerative disorders 
66
and enhancement of tumor growth (Maier et al, 
1994) which is partly associated with reduced 
immune response as a result of micronutrient 
depletion. Physiological stress has been reported 
to decrease plasma levels of vitamins A, E, B6
and C (Louw et al, 1991). During the past 
several years, major epidemiological studies 
have addressed the role of the antioxidant 
vitamins A, C, and E in the protection against 
cardiovascular and malignant diseases. A 
plausible conclusion from this emerging body 
of literature is that nutrient deficiency increases 
the risk for disease, and replacement of such 
deficiencies may be expected to confer benefits 
(Marcus and Coulston, 1996).  
Materials and Methods
Forty-two albino rats of wistar strain 
weighing between 200 to 300g were obtained 
from the animal house of the Department of 
Biochemistry, university of Calabar. They were 
kept under constant environmental and 
nutritional conditions throughout the 
experiment.  The animals were allowed free 
feeding with a standard diet and drinking water 
ad libitum.  They were divided into seven 
experimental groups, each consisting of six rats 




Group 4: Paracetamol + vitamin A
Group 5: Paracetamol + vitamin E
Group 6:Cafeinated paracetamol + 
Vitamin A
Group 7:Cafeinated paracetamol + 
Vitamin E
Cafeinated paracetamol and paracetamol 
were administered as caffeinated and non-
caffeinated paracetamol, using oral doses of 
171.43mg/kg. Vitamin E acetate (Ephynal) and 
vitamin A acetate were administered as vitamins 
E and A using oral doses of 4.286mg/kg and 
1428.57 i.u/kg respectively. At the end of the 
treatment period of 14 days, the animals were 
sacrificed after overnight fasting. Blood was 
collected into plane screw cap bottles for serum 
collection: this was allowed to stand for 2 hours 
for clotting to take place.  The serum was 
removed using a Pasteur pipette into another set 
of tubes, after spinning in a MSE clinical 
centrifuge at 1000rpm for 5 minutes.  Serum 
protein was estimated using the Biuret method 
of Doninger et al., 1972. Alanine amino 
transferase and Aspartate aminotransferase 
activities were determined by the method of 
Mathieu et al., 1982.  Alkaline phosphatase 
activity in serum was estimated by kit method 
of Tietz, (1982); which is based on the 
measurement of the rate of hydrolysis of 
phosphate esters. 
Statistical Analysis
Students’ t – test and analysis of variance 
(ANOVA) were used to analyze the data.  
Values of P<0.05 were regarded as significant.
Results
The total serum protein and the 
concentration of some liver enzymes in serum 
were measured in rats undergoing treatments 
with caffeinated and non-caffeinated 
paracetamol alone as well as those supplements 
with vitamins A and E and in control rats. 
Enzymes assayed were Alanine 
aminotransferase (ALT), Aspartate 
aminotransferase (AST) and Alkaline phosphate 
(ALP). The effect of treatment on these 
parameters is shown in table1. The total serum 
protein and the concentrations of enzymes 
measured were observed to vary significantly 
(p<0.05) among and within the test groups and 
the control. From the results obtained, There 
was a significant increase (p< 0.05) in total 
serum protein of the groups on cafeinated 
paracetamol (7.53  1.07) and paracetamol + 
Vitamin E (8.58  0.81) as well as a significant 
decrease in the group on cafeinated paracetamol 
+ Vitamin A (4.66  0.43) compared to the 
paracetamol group. The protein content 
(g/100ml) was however significantly reduced (p 
< 0.05) in the cafeinated paracetamol + Vitamin 
A group (4.66  0.43) compared to the 
cafeinated paracetamol group (7.53  1.07) and 
significantly increased (p < 0.05) in the
paracetamol + Vitamin E group (8.58  0.81) 
compared to the paracetamol + Vitamin A 
group (6.29  1.05) compared to the cafeinated 
paracetamol + vitamin A group.
The concentration of ALP (U/L) in the 
paracetamol treated group (121.90  10.62) was 
significantly higher (p < 0.05) than that of the 
control group (76.01  2.81). The reductions in 
ALP (U/L) in the groups on cafeinated 
paracetamol, paracetamol + Vitamin A, 
paracetamol + Vitamin E, cafeinated 
paracetamol + Vitamin A and cafeinated 
paracetamol + Vitamin E were significant (p < 
0.05) compared to the paracetamol group. Co-
administration of Vitamin A with cafeinated 
paracetamol (59.93  4.89) produced a 
significant reduction (p < 0.05) in ALP (U/L) 
compared with the cafeinated paracetamol 
group. There was however a significant increase 
(p < 0.05) in ALP (U/L) in the cafeinated 
paracetamol + Vitamin A group (59.93  4.89).
There were significant differences (p < 
0.05) in ALT and AST (U/L) among and within 
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the test groups. Paracetamol administration 
produced significant increases (p < 0.05) in both 
AST and ALT (U/L) (28.28  1.96 and 114.34 
0.55) compared to the control group (17.51 
1.42 and 73.81  1.45). There were significant 
decreases (p<0.05) in AST and ALT in the 
cafeinated paracetamol paracetamol + Vitamin 
A. cafeinated paracetamol + Vitamin A groups 
compared to the paracetamol  group. cafeinated 
paracetamol + Vitamin E however produced a 
significant increase (p<0.05) in ALT (U/L) 
(121.44  1.82) compared to the paracetamol 
group.
There was a significant decrease (p<0.05) 
in ALT (U/L) in the cafeinated paracetamol + 
Vitamin A group (73.61  0.80) compared to 
the cafeinated paracetamol group (89.00  0.70) 
as well as a significant increase (p < 0.05) in the 
cafeinated paracetamol + Vitamin E group 
compared to the cafeinated paracetamol group. 
Co-administration of Vitamin E produced 
significant decreases (p < 0.05) in AST (U/L) 
when administered with paracetamol and 
cafeinated paracetamol when compared to the 
cafeinated paracetamol group. Administration 
of cafeinated paracetamol + Vitamin E also 
produced a significant increase (p < 0.05) in 
ALT (U/L) compared to the cafeinated 
paracetamol + Vitamin A group.
  Table 1: Total serum protein and enzymes activities in rats given oral doses of paracetamol or 
panadol extra with or without vitamin A and E.
Group Treatment Total Serum 
Protein 
(g/100ml)
AST (U/L) ALT (U/L) ALP (U/L)
1 Control 5.98   0.65 17.51  1.42 73.81  1.45 76.01  2.81
2 Paracetamol 5.93  0.68b 28.28  1.96a 114.34  0.55a 121.90  10.62a
3 Panadol Extra 7.53  1.07* 23.54  0.84* 89.00  0.70* 87.97  2.06*
4 Paracetamol + 
Vitamin A
6.46  0.86• 20.57  0.70* 92.23  0.53* 64.5  3.40*
5 Paracetamol + 
Vitamin E
8.58  0.81* 20.30  0.72* 83.35  0.97* 68.87  7.87*
6 Panadol Extra 
+ Vitamin A
4.66  0.43* 23.67  0.96* 73.61  0.80* 59.93  4.89*
7 Panadol Extra  
+ Vitamin E
6.29  1.05• 18.83  0.59* 121.44  1.82* 84.75  4.27*
Values presented as mean  SD; n = 6; * p< 0.05 compared to the paracetamol group, *p< 0.05 compared to the 
paracetamol group, a p< 0.05 compared to the control, b p> 0.05 compared to control. Dose of paracetamol = 
171.43 mg/kg, Dose of paracetamol in cafeinated paracetamol =171.43mg/kg, Dose of caffeine in cafeinated 
paracetamol = 10.286mg/kg, Dose of Vitamin A = 4.286 mg/kg, Dose of Vitamin E = 1428.57 iu/ kg.
Discussion
Paracetamol administration produced a 
decrease in total serum protein while caffeinated 
paracetamol as well as supplementation with 
antioxidant vitamins A and E caused increases 
in total serum protein above that of the control 
group. However, the co-administration of 
vitamin A and paracetamol extra resulted in a 
decrease in total protein.
The commonest enzymes employed as 
indicators of hepatocellular damage are the 
transaminase enzymes (Aspartate 
aminotransferase; AST and Alanine 
aminotransferase; ALT) and Alkaline 
phosphatase; ALP. Damage to the liver results 
in increase in their activities in plasma. 
Increases in serum enzyme activities are 
roughly proportional to the extent of tissue 
damage (Gaw et al, 1995). Serum enzyme 
activities such as AST, ALT and ALP were 
increased following paracetamol administration. 
Similarly, the caffeination of paracetamol 
resulted in a reduction in the level of these 
enzymes.  Further reductions were observed 
following the administration of vitamins A and 
E; however the administration of vitamin E 
alongside with caffeinated paracetamol resulted 
in increased levels of ALP and ALT. 
Increase in liver enzymes in serum 
following paracetamol administration has earlier 
been reported (Gaw et al, 1995 and Hardman et 
al, 1996). It has also been reported that 
paracetamol could be bioactivated 
enzymatically by cytochrome P450 2EI in both 
the liver and the kidney (Hu et al, 1993). 
Metabolic activation by cytochrome P450 and 
prostaglandin synthase are known to catalyse 
the conversion of paracetamol to the reactive 
Antioxidant vitamins and paracetamol hepatotoxicity  
68
intermediate, N-acetyl parabenzoquinoneimine 
(NAPQI) which is believed to play an important 
role in paracetamol mediated toxicity (Raucy et 
al, 1989). Proinflammatory cytokines such as 
tumor necrosis factor alpha (TNF-) and 
interleukin-1, that are released in response t 
paracetamol intoxication are thought to be 
responsible for some pathlogical manifestations 
of paracetamol-induced hepatotoxicity (Blazka 
et al, 1995).
 The cumulative oxidative damage is likely 
one of the mechanisms producing the 
hepatotoxic effects of paracetamol 
administration in this study.  The observed 
higher increase in the level of ALT over AST 
may be due to a leakage of cytoplasmic 
enzymes into circulation as a result of 
inflammation of the liver cells. The molecular 
mechanism by which the antioxidant vitamins, 
and caffeine reduce liver damage maybe due to 
their ability to maintain liver cell integrity even 
in the presence of a hepatotoxic agent such as 
paracetamol.
Conclusion
         This study reveals that vitamins A and E 
as will as caffeine have protective roles in the 
maintenance of liver cell integrity even in the 
presence of a hepatotoxic agent such as 
paracetamol.
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